Boel Mörck, Rille Pullerits, Mats Geijer, Tomas Bremell, & Helena Forsblad-d'Elia. (2013). Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study. Hindawi Limited.
Chicago Style (17th ed.) CitationBoel Mörck, Rille Pullerits, Mats Geijer, Tomas Bremell, and Helena Forsblad-d'Elia. Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study. Hindawi Limited, 2013.
MLA (9th ed.) CitationBoel Mörck, et al. Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study. Hindawi Limited, 2013.
Warning: These citations may not always be 100% accurate.